John Doyle, 60, suffered complications after his transplant and could have been saved, but senior doctors - under pressure ...

Survivors of nodding syndrome need ongoing medical treatment, skills training for livelihood support, social integration, and ...

Overtreatment of prostate cancer is increasing in the United States among men with limited life expectancy, a new s ...

with an initial rollout expected for phase 3 tests of Sanofi’s multiple sclerosis meds. Here’s how the tool is designed: ...

The MS-STAT2 trial of a high-dose simvastatin has failed to slow progression of disability in patients with secondary ...

New data suggest the frequency of damage and repair processes correlates with disease severity and disability in multiple ...

The following is a summary of “A qualitative study on the experiences of autologous haematopoietic stem cell transplant for Multiple Sclerosis,” published in the November 2024 issue of Neurology by ...

“If we had had that capacity, we could certainly have treated thousands more patients… as well as being more resilient going into the second wave of the pandemic and into winter more generally,” Ms ...

and SPMS represents the later stages of MS. MS is typically diagnosed between the ages of 20 and 40 years, and patients usually progress from RRMS to SPMS around the age of 50. As the disease ...

The paper’s findings have significant implications for individuals diagnosed with MS as well as for clinicians treating ...

Binod Dhakal, MD, MS, discusses some of the next steps for evaluating ciltacabtagene autoleucel in multiple myeloma and the CARTITUDE-4 trial.

The complex relationship between possibly impaired cognitive function in patients with multiple sclerosis (MS) and fasting ...